SOHO 4th Italian Conference

www.sohoitaly.com

 

SOHO Italy 2022 on the Phase 2/3 HARBOR Study: BLU-263 in Patients With Indolent Systemic Mastocytosis and Monoclonal Mast Cell Activation Syndrome

18 views
December 1, 2022
Comments 0
Login to view comments. Click here to Login